RYN vs. PCH, BCC, PLD, STAG, WY, OHI, CUBE, HR, RHP, and SBRA
Should you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Potlatch (PCH), Boise Cascade (BCC), Prologis (PLD), Stag Industrial (STAG), Weyerhaeuser (WY), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Healthcare Realty Trust (HR), Ryman Hospitality Properties (RHP), and Sabra Healthcare REIT (SBRA).
Rayonier vs. Its Competitors
Rayonier (NYSE:RYN) and Potlatch (NASDAQ:PCH) are both mid-cap construction companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.
In the previous week, Potlatch had 1 more articles in the media than Rayonier. MarketBeat recorded 3 mentions for Potlatch and 2 mentions for Rayonier. Rayonier's average media sentiment score of 1.35 beat Potlatch's score of 0.99 indicating that Rayonier is being referred to more favorably in the media.
Rayonier has a net margin of 68.53% compared to Potlatch's net margin of 3.94%. Rayonier's return on equity of 3.39% beat Potlatch's return on equity.
Rayonier has higher revenue and earnings than Potlatch. Rayonier is trading at a lower price-to-earnings ratio than Potlatch, indicating that it is currently the more affordable of the two stocks.
Rayonier pays an annual dividend of $1.09 per share and has a dividend yield of 4.1%. Potlatch pays an annual dividend of $1.80 per share and has a dividend yield of 4.3%. Rayonier pays out 22.0% of its earnings in the form of a dividend. Potlatch pays out 339.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Rayonier presently has a consensus target price of $28.00, suggesting a potential upside of 6.37%. Potlatch has a consensus target price of $49.83, suggesting a potential upside of 18.78%. Given Potlatch's stronger consensus rating and higher possible upside, analysts clearly believe Potlatch is more favorable than Rayonier.
Rayonier has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500. Comparatively, Potlatch has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.
89.1% of Rayonier shares are owned by institutional investors. Comparatively, 86.1% of Potlatch shares are owned by institutional investors. 0.8% of Rayonier shares are owned by company insiders. Comparatively, 1.0% of Potlatch shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
Rayonier beats Potlatch on 10 of the 18 factors compared between the two stocks.
Get Rayonier News Delivered to You Automatically
Sign up to receive the latest news and ratings for RYN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RYN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Rayonier Competitors List
Related Companies and Tools
This page (NYSE:RYN) was last updated on 10/7/2025 by MarketBeat.com Staff